SCHEMBL2645447

SCHEMBL2645447

O=C(CC(=O)c1ccccc1)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
KMT2A Q03164 3/20 0.61
TDP1 Q9NUW8 3/20 0.61
MAPK1 P28482 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
SLC6A2 P23975 1/20 0.61
SLC6A3 Q01959 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
CYP3A4 P08684 1/20 0.57
MAPT P10636 1/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
CES1 P23141 1/20 0.57
LMNA P02545 4/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
PTPN1 P18031 2/20 0.50
ERCC5 P28715 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5370096 0.91 ALDH1A1 (0.56) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL13748438 0.89 NPC1 (0.62) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL12159688 0.89 KMT2A (0.58) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL10252731 0.89 ALDH1A1 (0.53) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL28488994 0.87 ERCC5 (0.60) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL5754659 0.87 RAB9A (0.59) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL294341 0.86 ALDH1A1 (0.73) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL16321874 0.86 ALDH1A1 (0.57) ALDH1A1KMT2AL3MBTL1SMN1; SMN2KDM4E
SCHEMBL5751558 0.85 ALDH1A1 (0.66) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
SCHEMBL8069055 0.84 ALDH1A1 (0.70) ALDH1A1KMT2ATDP1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735178-B2 Withanolides, probes and binding targets and methods of use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-05-27 US claimed
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF KENTUCKY RESEARCH FOUNDATION 2008-08-28 US claimed
WO-2008101109-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2008-08-21 WO claimed
CN-109053678-B Preparation method of benzo [ b ] thiophene-3 (2H) -ketone-1, 1-dioxide 乐平市科乐化学科技有限公司 2022-05-27 CN disclosed
US-20180327695-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2018-11-15 US disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
WO-2017071874-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2017-05-04 WO disclosed
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2016-12-01 US disclosed
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2016-12-01 US disclosed
WO-2015124671-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-08-27 WO disclosed
US-8735178-B2 Withanolides, probes and binding targets and methods of use thereof UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-05-27 US disclosed
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF KENTUCKY RESEARCH FOUNDATION 2008-08-28 US disclosed
WO-2008101109-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2008-08-21 WO disclosed
EP-0871444-A4 2,5-SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO INC (US) 1999-01-13 EP disclosed
US-5837719-A USEFUL FOR TREATING CYTOKINE MEDIATED DISEASES, INFLAMMATION,SHOCK, ARTHRITIS, RESPIRATORY DISORDERS, THROMBOSIS, VIRAL INFECTION, GASTROINTESTINAL DISORDERS MERCK & CO., INC. (US) 1998-11-17 US disclosed
EP-0871444-A1 2,5-SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 1998-10-21 EP disclosed
WO-1997016441-A1 SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 1997-05-09 WO disclosed
WO-1997005878-A1 2,5-SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 1997-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES CUTA, FAAH, FAAH2 ALDH1A1 94/4885KMT2A 977/4885TDP1 3111/4885
US-20180327695-A1 PHOTOLABILE PRO-FRAGRANCES CUTA, CRY1, LAGE3 ALDH1A1 270/4885KMT2A 2087/4885TDP1 2437/4885
US-20080207574-A1 WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF VIM, HASPIN, FABP3 ALDH1A1 2226/4885KMT2A 3568/4885TDP1 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.